Hanan H. Beherei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hanan H. Beherei has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Khaled Rezk Mohamed
National Research Center, Egypt
7 shared publications - Gehan El Tabie El-Bassyouni
Refractories, Ceramics and Building Materials Department, National Research Centre, Dokki, Egypt
5 shared publications - Mostafa Mabrouk
Refractories, Ceramics and Building Materials Department, National Research Centre, 33 El Bohouth St. (Former EL Tahrir St.), Dokki, Giza 12622, Egypt
3 shared publications - Hadeer A. Aglan
Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt
2 shared publications - Hanaa Hamdy Ahmed
Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt
2 shared publications - Ahmed A. Abd-Rabou
Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt
1 shared publication
Latest Publications
- Open Access
- 30 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-19
Novel Biocompatible Hyaluronic Acid (HA)/Polyvinylpyrrolidone (PVP) Composites Containing Silver Decorated-Zinc MOF Nanoparticles: Antimicrobial Activity, Drug Delivery and Wound Healing
Chronic infected wounds with multi-drug resistant pathogens present severe therapeutic challenges, often leading to prolonged morbidity and impaired healing. To address this, we engineered a multifunctional wound dressing by integrating Voriconazole-loaded silver/zinc MOFs (VOR@Ag/Zn-MOFs) into a hyaluronic acid/polyvinylpyrrolidone (HA/PVP) matrix. The composite was prepared through sequential steps, including preparing a HA/PVP polymer blend via solvent dissolution, synthesizing bimetallic Ag/Zn-MOFs through chemical precipitation, loading VOR into MOF nanocages, and consolidating the composite via chemical crosslinking followed by freeze-drying. Comprehensive physicochemical characterization to confirm MOF stability was implemented through SEM/EDX, confirming uniform nanocage architecture and elemental distribution (Ag/Zn/F), while DLS revealed controlled particle dimensions, and optimal colloidal stability (PDI 0.694; ZP + 39.3 mV). FTIR confirmed structural integrity through preserved polymer peaks (O–H 3400–3200, C = O 1650 cm⁻1), VOR-specific C-F (1400–1200 cm⁻1), and MOF Zn–O bonds (1100–1000/400–600 cm⁻1), verifying non-covalent integration without degradation. XRD further verified the crystalline framework integrity. In-vitro release studies demonstrated sustained biphasic release (44.2% ± 5.9 burst within 6 h; up to 77.1% ± 1.8 controlled release over 360 h). The composite demonstrated exceptional antimicrobial synergy, including potent antifungal activity against Candida albicans (MFC 1.4 µg/mL, 214-fold lower than free VOR) with microscopically-confirmed cell wall disruption, and broad bacteriostatic activity (MIC range 8,500–17,000 µg/mL against Gram-positive and Gram-negative pathogens). Critically, it achieved complete fungal clearance within 24 h. Simultaneously, it accelerated tissue regeneration, showing outstanding fibroblast biocompatibility (IC₃₀ > 3,000 µg/mL; 6,000-fold safety margin) and enabling marked wound closure within 72 h in the wound healing study. By converging triple-action mechanisms, including metal ion synergy (Ag⁺/Zn2⁺), targeted azole delivery, and HA/PVP-mediated pro-regenerative signaling, this platform uniquely eliminates resilient infections and restores wound integrity that was previously unattainable with conventional azole therapies. Graphical Abstract
- 30 October 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-19
Open AccessNovel Biocompatible Hyaluronic Acid (HA)/Polyvinylpyrrolidone (PVP) Composites Containing Silver Decorated-Zinc MOF Nanoparticles: Antimicrobial Activity, Drug Delivery and Wound Healing
Chronic infected wounds with multi-drug resistant pathogens present severe therapeutic challenges, often leading to prolonged morbidity and impaired healing. To address this, we engineered a multifunctional wound dressing by integrating Voriconazole-loaded silver/zinc MOFs (VOR@Ag/Zn-MOFs) into a hyaluronic acid/polyvinylpyrrolidone (HA/PVP) matrix. The composite was prepared through sequential steps, including preparing a HA/PVP polymer blend via solvent dissolution, synthesizing bimetallic Ag/Zn-MOFs through chemical precipitation, loading VOR into MOF nanocages, and consolidating the composite via chemical crosslinking followed by freeze-drying. Comprehensive physicochemical characterization to confirm MOF stability was implemented through SEM/EDX, confirming uniform nanocage architecture and elemental distribution (Ag/Zn/F), while DLS revealed controlled particle dimensions, and optimal colloidal stability (PDI 0.694; ZP + 39.3 mV). FTIR confirmed structural integrity through preserved polymer peaks (O–H 3400–3200, C = O 1650 cm⁻1), VOR-specific C-F (1400–1200 cm⁻1), and MOF Zn–O bonds (1100–1000/400–600 cm⁻1), verifying non-covalent integration without degradation. XRD further verified the crystalline framework integrity. In-vitro release studies demonstrated sustained biphasic release (44.2% ± 5.9 burst within 6 h; up to 77.1% ± 1.8 controlled release over 360 h). The composite demonstrated exceptional antimicrobial synergy, including potent antifungal activity against Candida albicans (MFC 1.4 µg/mL, 214-fold lower than free VOR) with microscopically-confirmed cell wall disruption, and broad bacteriostatic activity (MIC range 8,500–17,000 µg/mL against Gram-positive and Gram-negative pathogens). Critically, it achieved complete fungal clearance within 24 h. Simultaneously, it accelerated tissue regeneration, showing outstanding fibroblast biocompatibility (IC₃₀ > 3,000 µg/mL; 6,000-fold safety margin) and enabling marked wound closure within 72 h in the wound healing study. By converging triple-action mechanisms, including metal ion synergy (Ag⁺/Zn2⁺), targeted azole delivery, and HA/PVP-mediated pro-regenerative signaling, this platform uniquely eliminates resilient infections and restores wound integrity that was previously unattainable with conventional azole therapies. Graphical Abstract
- Open Access
- 15 August 2022
- Published by Springer Nature in Neurotoxicity Research
- Vol. 40 (5) , 1479-1498
Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity
Cisplatin (CIS) is a platinum-based chemotherapeutic drug that is widely used to treat cancer. However, its therapeutic efficiency is limited due to its potential to provoke neurotoxicity. Sulforaphane (SF) is a natural phytochemical that demonstrated several protective activities. Iron oxide nanoparticles (Fe3O4-NPs) could be used as drug carriers. This study aimed to explore the nanotoxic influence of SF-loaded within Fe3O4-NPs (N.SF), and to compare the neuroprotective potential of both N.SF and SF against CIS-induced neurotoxicity. N.SF or SF was administrated intranasally for 5 days before and 3 days after a single dose of CIS (12 mg/kg/week, i.p.) on the 6thday. Neuromuscular coordination was assessed using hanging wire and tail-flick tests. Acetylcholinesterase (AChE) activities and markers of oxidative stress were measured in the brain. In addition, the brain iron (Fe) content was estimated. CIS significantly induced a significant increase in AChE activities and lipid peroxides, and a significant decrement in glutathione (GSH) and nitric oxide (NO) contents. CIS elicited impaired neuromuscular function and thermal hyperalgesia. CIS-induced brains displayed a significant reduction in Fe content. Histopathological examination of different brain regions supported the biochemical and behavioral results. Contradict, treatment of CIS-rats with either N.SF or SF significantly decreased AChE activity, mitigated oxidative stress, and ameliorated the behavioral outcome. The histopathological features supported our results. Collectively, N.SF demonstrated superior neuroprotective activities on the behavioral, biochemical, and histopathological (striatum and cerebral cortex) aspects. N.SF could be regarded as a promising “pre-clinical” neuroprotective agent. Furthermore, this study confirmed the safe toxicological profile of Fe3O4-NPs.
- 15 August 2022
- Published by Springer Nature in Neurotoxicity Research
- Vol. 40 (5) , 1479-1498
Open AccessNeuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity
Cisplatin (CIS) is a platinum-based chemotherapeutic drug that is widely used to treat cancer. However, its therapeutic efficiency is limited due to its potential to provoke neurotoxicity. Sulforaphane (SF) is a natural phytochemical that demonstrated several protective activities. Iron oxide nanoparticles (Fe3O4-NPs) could be used as drug carriers. This study aimed to explore the nanotoxic influence of SF-loaded within Fe3O4-NPs (N.SF), and to compare the neuroprotective potential of both N.SF and SF against CIS-induced neurotoxicity. N.SF or SF was administrated intranasally for 5 days before and 3 days after a single dose of CIS (12 mg/kg/week, i.p.) on the 6thday. Neuromuscular coordination was assessed using hanging wire and tail-flick tests. Acetylcholinesterase (AChE) activities and markers of oxidative stress were measured in the brain. In addition, the brain iron (Fe) content was estimated. CIS significantly induced a significant increase in AChE activities and lipid peroxides, and a significant decrement in glutathione (GSH) and nitric oxide (NO) contents. CIS elicited impaired neuromuscular function and thermal hyperalgesia. CIS-induced brains displayed a significant reduction in Fe content. Histopathological examination of different brain regions supported the biochemical and behavioral results. Contradict, treatment of CIS-rats with either N.SF or SF significantly decreased AChE activity, mitigated oxidative stress, and ameliorated the behavioral outcome. The histopathological features supported our results. Collectively, N.SF demonstrated superior neuroprotective activities on the behavioral, biochemical, and histopathological (striatum and cerebral cortex) aspects. N.SF could be regarded as a promising “pre-clinical” neuroprotective agent. Furthermore, this study confirmed the safe toxicological profile of Fe3O4-NPs.
- Open Access
- 1 August 2022
- Published by Taylor & Francis in Future Science OA
- Vol. 8 (7) , FSO811
The Promising Role of hypoxia-resistant insulin-producing Cells in Ameliorating Diabetes Mellitus In Vivo
Aim: This study aimed to evaluate the efficacy of hypoxia-persistent insulin-producing cells (IPCs) against diabetes in vivo. Materials & methods: Mesenchymal stem cells (MSCs) differentiation into... Plain language summary Transplantation of cells that can release insulin have been reported as an alternate method to islet transfer for curing diabetes; however, the main difficulty facing the qua... Graphical abstract
- 1 August 2022
- Published by Taylor & Francis in Future Science OA
- Vol. 8 (7) , FSO811
Open AccessThe Promising Role of hypoxia-resistant insulin-producing Cells in Ameliorating Diabetes Mellitus In Vivo
Aim: This study aimed to evaluate the efficacy of hypoxia-persistent insulin-producing cells (IPCs) against diabetes in vivo. Materials & methods: Mesenchymal stem cells (MSCs) differentiation into... Plain language summary Transplantation of cells that can release insulin have been reported as an alternate method to islet transfer for curing diabetes; however, the main difficulty facing the qua... Graphical abstract
- 1 November 2021
- Published by Springer Nature in BioNanoScience
- Vol. 12 (1) , 1-12
The Anticancer Effect of Magnetic Selenium-Based Nanocomposites on Tongue Carcinoma Stem Cells (In Vitro Study)
- 1 November 2021
- Published by Springer Nature in BioNanoScience
- Vol. 12 (1) , 1-12
The Anticancer Effect of Magnetic Selenium-Based Nanocomposites on Tongue Carcinoma Stem Cells (In Vitro Study)
- 12 February 2019
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 30 (2) , 24
Enhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocomposites
The main target of this work was to explore the proliferative impact of selenium dioxide nanoparticles (SeO2) and selenium dioxide/titanium dioxide nanocomposites (Se/Ti (I), (II) and (III)) on mesenchymal stem cells (MSCs). For this purpose, SeO2 and Se/Ti (I), (II) and (III) were prepared by facile one step method and characterized by transmission electron microscopy (TEM), Zetasizer, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and scanning electron microscope (SEM) along with energy-dispersive X-ray spectrometry (EDX) with reference to SeO2 nanoparticles. Also, MSCs were isolated from rat bone marrow (BM-MSCs) and adipose tissue (ADSCs), propagated and characterized by flow cytometry. Thereafter, the proliferative effect of the fabricated nanomaterials was investigated by MTT assay. The TEM and DLS results, revealed that the average particle size of the suggested nanomaterials was in nanoscale. XRD pattern showed well crystalline structure for SeO2 nanoparticles and Se/Ti (I), (II) and (III) nanocomposites; the decreasing of the crystalline phase was observed by increasing the wt% of TiO2. The designed nanomaterials showed proliferative effects on MSCs with the most prominent effect exerted by 2 µg/ml of Se/Ti (III) and 5 µg/ml of Se/Ti (II) for ADSCs and 20 µg/ml of Se/Ti (II) and 10 µg/ml of Se/Ti (III) for BM-MSCs. Therefore, these newly designed nanomaterials have a promising influence on MSCs proliferation and they are recommended to be utilized in the filed of tissue engineering.
- 12 February 2019
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 30 (2) , 24
Enhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocomposites
The main target of this work was to explore the proliferative impact of selenium dioxide nanoparticles (SeO2) and selenium dioxide/titanium dioxide nanocomposites (Se/Ti (I), (II) and (III)) on mesenchymal stem cells (MSCs). For this purpose, SeO2 and Se/Ti (I), (II) and (III) were prepared by facile one step method and characterized by transmission electron microscopy (TEM), Zetasizer, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR) and scanning electron microscope (SEM) along with energy-dispersive X-ray spectrometry (EDX) with reference to SeO2 nanoparticles. Also, MSCs were isolated from rat bone marrow (BM-MSCs) and adipose tissue (ADSCs), propagated and characterized by flow cytometry. Thereafter, the proliferative effect of the fabricated nanomaterials was investigated by MTT assay. The TEM and DLS results, revealed that the average particle size of the suggested nanomaterials was in nanoscale. XRD pattern showed well crystalline structure for SeO2 nanoparticles and Se/Ti (I), (II) and (III) nanocomposites; the decreasing of the crystalline phase was observed by increasing the wt% of TiO2. The designed nanomaterials showed proliferative effects on MSCs with the most prominent effect exerted by 2 µg/ml of Se/Ti (III) and 5 µg/ml of Se/Ti (II) for ADSCs and 20 µg/ml of Se/Ti (II) and 10 µg/ml of Se/Ti (III) for BM-MSCs. Therefore, these newly designed nanomaterials have a promising influence on MSCs proliferation and they are recommended to be utilized in the filed of tissue engineering.
- 1 December 2014
- Published by Springer Nature in Interceram - International Ceramic Review
- Vol. 63 (7-8) , 386-392
Mechanical and Bioactivity Properties of Nano Ceramic Composite-Based Oxyapatite Materials
- 1 December 2014
- Published by Springer Nature in Interceram - International Ceramic Review
- Vol. 63 (7-8) , 386-392
Mechanical and Bioactivity Properties of Nano Ceramic Composite-Based Oxyapatite Materials
- Open Access
- 1 March 2014
- Published by Elsevier in Journal of Advanced Research
- Vol. 5 (2) , 201-208
In vitro study of nano-hydroxyapatite/chitosan–gelatin composites for bio-applications
- 1 March 2014
- Published by Elsevier in Journal of Advanced Research
- Vol. 5 (2) , 201-208
Open AccessIn vitro study of nano-hydroxyapatite/chitosan–gelatin composites for bio-applications
- 1 October 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (7) , 4126-4132
Fabrication and mechanical evaluation of hydroxyapatite/oxide nano-composite materials
- 1 October 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (7) , 4126-4132
Fabrication and mechanical evaluation of hydroxyapatite/oxide nano-composite materials
- 7 January 2010
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 116 (4) , 2083-2094
Preparation, characterization, and in vitro application of composite films based on gelatin and collagen from natural resources
This work aims to prepare and characterize a new generation composite films with gelatins extracted from bovine and bird bones (Gb and Gc, respectively) in addition to collagen, hide powder, (HP) which are blended with copolymerized polyethylene (MPE) and low density polyethylene, using polymer melt technique, which may be suitable for application as a base material for dental and orthopedic implants with better biological response. The bone‐bonding ability of the composite films was evaluated by examining the ability of apatite to form on their surface in a simulated body fluid (SBF) with ion concentrations nearly equal to those of human blood plasma. The examination of apatite formation on the composites after immersion in SBF for 7 days was carried out by Fourier transform infrared spectroscopy and scanning electron microscopy with energy dispersive X‐ray. The results showed the formation of thick apatite layer on the surface of the biocomposite films in special way on these containing Gb/MPE and collagen/MPE. Promising results have been achieved indicating that these novel biocomposites have unique bioactivity properties, which can be applied in bone implants and tissue engineering applications as scaffolds in future. © 2010 Wiley Periodicals, Inc. J Appl Polym Sci, 2010
- 7 January 2010
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 116 (4) , 2083-2094
Preparation, characterization, and in vitro application of composite films based on gelatin and collagen from natural resources
This work aims to prepare and characterize a new generation composite films with gelatins extracted from bovine and bird bones (Gb and Gc, respectively) in addition to collagen, hide powder, (HP) which are blended with copolymerized polyethylene (MPE) and low density polyethylene, using polymer melt technique, which may be suitable for application as a base material for dental and orthopedic implants with better biological response. The bone‐bonding ability of the composite films was evaluated by examining the ability of apatite to form on their surface in a simulated body fluid (SBF) with ion concentrations nearly equal to those of human blood plasma. The examination of apatite formation on the composites after immersion in SBF for 7 days was carried out by Fourier transform infrared spectroscopy and scanning electron microscopy with energy dispersive X‐ray. The results showed the formation of thick apatite layer on the surface of the biocomposite films in special way on these containing Gb/MPE and collagen/MPE. Promising results have been achieved indicating that these novel biocomposites have unique bioactivity properties, which can be applied in bone implants and tissue engineering applications as scaffolds in future. © 2010 Wiley Periodicals, Inc. J Appl Polym Sci, 2010
- 1 July 2009
- Published by Elsevier in Ceramics International
- Vol. 35 (5) , 1991-1997
Fabrication and characterization of bioactive glass (45S5)/titania biocomposites
- 1 July 2009
- Published by Elsevier in Ceramics International
- Vol. 35 (5) , 1991-1997
Fabrication and characterization of bioactive glass (45S5)/titania biocomposites